Up a level |
Number of items: 1.
Middleton, Gary, Brock, Kristian, Savage, Joshua, Mant, Rhys, Summers, Yvonne, Connibear, John, Shah, Riyaz, Ottensmeier, Christian ORCID: 0000-0003-3619-1657, Shaw, Paul, Lee, Siow-Ming et al (show 4 more authors)
(2020)
Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial.
The Lancet Respiratory Medicine, 8 (9).
pp. 895-904.